Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;3(1):23-5.
doi: 10.2217/cns.13.57.

Brain cancer translational research from an academic perspective

Affiliations

Brain cancer translational research from an academic perspective

Gregory Riggins et al. CNS Oncol. 2014 Jan.

Abstract

Dr Gregory Riggins speaks to Simi Thankaraj, Assistant Commisioning Editor: Gregory J Riggins is the recipient of the Irving J Sherman MD Research Professorship in Neurosurgery and the Director of the Division of Neurosurgery Research. He received his MD and PhD degrees from Emory University (GA, USA) where he graduated from the Medical Scientist Training Program. After graduation, he then trained as a postdoctoral fellow with Bert Vogelstein and Ken Kinzler at the Johns Hopkins University (MD, USA) in the Department of Oncology. Now a Professor of Neurosurgery and Oncology, and Genetic Medicine at Johns Hopkins, the main goal of his research is to develop and evaluate new brain tumor therapies. A major component of this research is identifying new small molecules.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

G Riggins is a member of the scientific advisory board and receives compensation from Vanquish Oncology, which is developing PAC-1, a procaspase activator. He also receives proceeds from intellectual property related to the IDH1 mutation licenced by various for-profit companies. Both of these financial arrangements are managed by Johns Hopkins University in accordance with their conflict of interest policies. G Riggins has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

References

    1. Borodovsky A, Salmasi V, Turcan S, et al. 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget. 2013;4(10):1737–1747. - PMC - PubMed
    1. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc. Natl Acad. Sci. USA. 2001;98(26):15155–15160. - PMC - PubMed
    1. Krick EL, Sorenmo KU, Rankin SC, et al. Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors. Am. J. Vet. Res. 2012;73(1):112–118. - PMC - PubMed

Publication types

LinkOut - more resources